Nanjing Vishee Medical Technology Co., Ltd / Fundamentals

    Income statement

    Net revenue
    €49.02M
    Cost of goods sold
    €17.69M
    Gross profit
    €31.32M
    SG&A expenses
    €10.00M
    R&D expenses
    €5.25M
    EBITDA
    €16.26M
    D&A
    €728.03K
    EBIT
    €13.87M
    Interest expenses
    €161.17K
    EBT
    €15.37M
    Tax expenses
    €1.71M
    Net income
    €13.66M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €1.10M
    Changes in working capital
    -€66.15K
    Operating cash flow
    €7.17M
    Capex
    €12.36M
    Other investing cash flow
    €127.25K
    Net investing cash flow
    -€11.09M
    Total cash dividends paid
    -€12.31M
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    -€11.73M
    Net financing cash flow
    -€11.73M
    Foreign exchange effects
    -€69.34
    Net change in cash
    -€6.52M
    Cash at end of period
    €127.44M
    Free cash flow
    €19.53M

    Balance sheet

    Cash and cash equivalents
    €127.56M
    Cash and short-term investments
    €127.56M
    Total receivables
    €3.55M
    Inventory
    €4.37M
    Other current assets
    €3.68M
    Total current assets
    €139.17M
    Property, plant & equipment
    €49.68M
    Goodwill
    €8.35M
    Intangible assets
    €15.48M
    Long-term investments
    €0.24
    Other non-current assets
    €4.41M
    Total non-current assets
    €79.56M
    Total assets
    €218.73M
    Accounts payable
    €1.74M
    Short-term debt
    €0.00
    Other current liabilities
    €15.05M
    Total current liabilities
    €18.36M
    Long-term debt
    €121.23K
    Deferred tax liabilities
    €48.08K
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €169.31K
    Total liabilities
    €18.53M
    Common stock
    €11.54M
    Retained earnings
    €55.15M
    Other equity
    €0.00
    Total equity
    €200.20M
    Total liabilities and shareholders' equity
    €218.73M

    Company information

    Market capitalization
    €527.87M
    Employees
    700
    Enterprise Value
    €3.46B

    Company ratios

    Gross margin
    63.9% Better than peer group: 54.9%
    EBITDA margin
    33.2% Better than peer group: 17.4%
    EBIT margin
    28.3% Better than peer group: 10.8%
    EBT margin
    31.4% Better than peer group: 11.7%
    Net margin
    27.9% Better than peer group: 9.5%
    ROE
    6.8% Even with peer group: 7.3%
    ROA
    6.2% Even with peer group: 5.7%
    Asset turnover
    22.4% Much worse than peer group: 45.7%
    FCF margin
    -10.6% Even with peer group: -5.9%
    FCF yield
    -1.0%
    Efficiency ratio
    66.8%
    Net sales per employee
    €70.02K
    Net income per employee
    €19.52K

    Notifications